Are there mood stabilisers prescribed for ADHD-related mood swings?

PostedOctober 29, 2025

UpdatedOctober 29, 2025

ByMy Patient Advice

Author: Phoebe Carter, MSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

People with ADHD often experience emotional ups and downs, but these are not the same as mood episodes seen in bipolar disorder. While mood stabilisers (such as lithium, valproate, or lamotrigine) are sometimes discussed in ADHD care, they are not prescribed for ADHD alone. They are typically reserved for cases where ADHD coexists with a mood disorder such as bipolar disorder or severe mood dysregulation.

NHS and NICE guidance

According to the NICE ADHD guideline (NG87), recommended medications for ADHD include stimulants, atomoxetine, and guanfacine, not mood stabilisers. If a clinician suspects an underlying mood disorder, NICE recommends a specialist referral before any mood-stabilising medication is considered.

The NHS also notes that while ADHD can sometimes resemble bipolar disorder, treatments are entirely different. Stimulants and non-stimulants target attention and impulse control, whereas mood stabilisers are designed for cyclical mood episodes.

ADHD mood swings vs bipolar disorder

The Royal College of Psychiatrists (RCPsych) explains that ADHD-related mood changes are typically short-lived and reactive, triggered by frustration, rejection, or stress, while bipolar mood episodes last days or weeks and include distinct periods of mania or depression.
This difference is crucial because mood stabilisers only treat bipolar-type mood cycles, not the moment-to-moment reactivity seen in ADHD.

What research says about mood stabilisers and ADHD

A PubMed (2023) review found that drugs like valproate and lamotrigine are sometimes used off-label in adults with ADHD and coexisting emotional instability, but the evidence is limited. Similarly, Frontiers in Psychiatry (2024) reported that mood stabilisers may be explored in complex, treatment-resistant cases, but they are not part of standard ADHD care.

The Mayo Clinic confirms that mood stabilisers like lithium or valproate are reserved for mood disorders, not for ADHD itself. Instead, ADHD-related mood issues are usually managed through stimulants, atomoxetine, guanfacine, or CBT for emotional regulation.

When mood stabilisers may be used

The Cleveland Clinic (2024) notes that mood stabilisers are appropriate only when ADHD overlaps with bipolar disorder, cyclothymia, or severe mood dysregulation. In such cases, the mood disorder is treated first, often alongside ADHD medication.

When prescribed, mood stabilisers require careful monitoring, including blood tests for lithium or valproate as outlined in NICE bipolar guidance (CG185).

Preferred alternatives for emotional regulation

For ADHD-related mood reactivity, clinicians typically recommend:

Atomoxetine or guanfacine for impulsivity and emotional control

CBT or mindfulness training to build coping strategies

Parent or family-based education for children and teens

A Lancet Psychiatry (2024) study found that atomoxetine significantly reduced emotional lability and frustration tolerance issues in young people with ADHD without the risks associated with mood stabilisers.

Takeaway

Mood stabilisers are not standard ADHD treatments. They may only be prescribed when another mood disorder such as bipolar is confirmed. For most people with ADHD, mood swings are better managed through non-stimulant medications, structured routines, and CBT for emotional regulation.
If mood changes feel extreme or persistent, it’s important to discuss them with a clinician to ensure the right diagnosis and safest treatment plan.

Phoebe Carter, MSc

Author

Phoebe Carter is a clinical psychologist with a Master’s in Clinical Psychology and a Bachelor’s in Applied Psychology. She has experience working with both children and adults, conducting psychological assessments, developing individualized treatment plans, and delivering evidence-based therapies. Phoebe specialises in neurodevelopmental conditions such as autism spectrum disorder (ASD), ADHD, and learning disabilities, as well as mood, anxiety, psychotic, and personality disorders. She is skilled in CBT, behaviour modification, ABA, and motivational interviewing, and is dedicated to providing compassionate, evidence-based mental health care to individuals of all ages.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.